Analysis of the Validity of Perioperative Antibiotic Prophylaxis in Maxillofacial Surgery
Abstract
:1. Introduction
2. Materials and Methods
- a group of trauma patients undergoing osteosynthesis of facial cranial fractures (n = 43);
- a group of non-trauma patients who underwent a procedure other than osteosynthesis of fractures (n = 40).
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Kaczmarzyk, T.; Babiuch, K.; Bołtacz-Rzepkowska, E.; Dominiak, M.; Konopka, T.; Lipski, M.; Olczak-Kowalczyk, D.; Szeląg, A.; Szuta, M.; Hryniewicz, W. Polish Dental Association and National Programme To Protect Antibiotics Working Group recommendations for administration of antibiotics in dentistry. J. Stomatol. 2019, 71, 457–465. [Google Scholar] [CrossRef]
- Stanowisko Zespołu Roboczego, ds. Oznaczania Lekowrażliwości Zgodnie z Zaleceniami EUCAST w Sprawie Najczęściej Zgłaszanych Pytań Dotyczących Stosowania Rekomendacji EUCAST Wersja 4. Narodowy Program Ochrony Antybiotyków. 2020. Available online: https://korld.nil.gov.pl/pdf/strona_23-06-2020-Stanowisko_Zespolu_Roboczego.pdf (accessed on 22 September 2022).
- Bulanda, M.; Jawień, M. Perioperative antibiotic prophylaxis in prevention of surgical site infections. Zakażenia 2004, 4, 38–42. [Google Scholar]
- Lodi, G.; Figini, L.; Sardella, A.; Carrassi, A.; Del Fabbro, M.; Furness, S. Antibiotics to prevent complications following tooth extractions. Cochrane Database Syst. Rev. 2012, 11, CD003811. [Google Scholar] [CrossRef]
- Arteagoitia, I.; Ramos, E.; Santamaria, G.; Barbier, L.; Alvarez, J.; Santamaria, J. Amoxicillin/clavulanic acid 2000/125 mg to prevent complications due to infection following completely bone-impacted lower third molar removal: A clinical trial. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2015, 119, 8–16. [Google Scholar] [CrossRef] [PubMed]
- Napora, M. Antibiotic Prophylaxis by Patients with High Risk of Infective Endocarditis in Stomatology. Nowa Stomatol. 2008, 1, 24–26. [Google Scholar]
- Kuriyama, T.; Lewis, M.; Williams, D. Infections of the oral and maxillofacial region. In Oral and Maxillofacial Surgery; Wiley-Blackwell: Hoboken, NY, USA, 2010; pp. 467–582. ISBN 978-1-118-29256-3. [Google Scholar]
- Chrcanovic, B.R.; Albrektsson, T.; Wennerberg, A. Prophylactic antibiotic regimen and dental implant failure: A meta-analysis. J. Oral Rehabil. 2014, 41, 941–956. [Google Scholar] [CrossRef]
- Mawalla, B.; Mshana, S.E.; Chalya, P.L.; Imirzalioglu, C.; Mahalu, W. Predictors of surgical site infections among patients undergoing major surgery at Bugando Medical Centre in Northwestern Tanzania. BMC Surg. 2011, 11, 21. [Google Scholar] [CrossRef]
- Karakida, K.; Sakamoto, H.; Aoki, T.; Ota, Y.; Yamazaki, H.; Otsuru, M.; Takahashi, M.; Miyasaka, M. Analysis of risk factors for surgical-site infections in 276 oral cancer surgeries with microvascular free-flap reconstructions at a single university hospital. J. Infect. Chemother. 2010, 16, 334–339. [Google Scholar] [CrossRef]
- Shi, M.; Han, Z.; Qin, L.; Su, M.; Liu, Y.; Li, M.; Cheng, L.; Huang, X.; Sun, Z. Risk factors for surgical site infection after major oral oncological surgery: The experience of a tertiary referral hospital in China. J. Int. Med. Res. 2020, 48, 0300060520944072. [Google Scholar] [CrossRef]
- Davis, C.M.; Gregoire, C.E.; Steeves, T.W.; Demsey, A. Prevalence of Surgical Site Infections Following Orthognathic Surgery: A Retrospective Cohort Analysis. J. Oral Maxillofac. Surg. J. 2016, 74, 1199–1206. [Google Scholar] [CrossRef]
- Remschmidt, B.; Schwaiger, M.; Gaessler, J.; Wallner, J.; Zemann, W.; Schwaiger, M. Surgical site infections in orthognathic surgery: Prolonged versus single-dose antibiotic prophylaxis. Int. J. Oral Maxillofac. Surg. 2022, in press. [Google Scholar] [CrossRef] [PubMed]
- Abu-Ta’a, M. Adjunctive Systemic Antimicrobial Therapy vs Asepsis in Conjunction with Guided Tissue Regeneration: A Randomized, Controlled Clinical Trial. J. Contemp. Dent. Pract. 2016, 17, 3–6. [Google Scholar] [CrossRef]
- Funahara, M.; Yanamoto, S.; Ueda, M.; Suzuki, T.; Ota, Y.; Nishimaki, F.; Kurita, H.; Yamakawa, N.; Kirita, T.; Okura, M.; et al. Prevention of surgical site infection after oral cancer surgery by topical tetracycline. Medicine 2017, 96, e8891. [Google Scholar] [CrossRef]
- Bortoluzzi, M.C.; Capella, D.L.; Barbieri, T.; Pagliarini, M.; Cavalieri, T.; Manfro, R. A single dose of amoxicillin and dexamethasone for prevention of postoperative complications in third molar surgery: A randomized, double-blind, placebo controlled clinical trial. J. Clin. Med. Res. 2013, 5, 26–33. [Google Scholar] [CrossRef]
- Lindeboom, J.A.H.; van den Akker, H.P. A prospective placebo-controlled double-blind trial of antibiotic prophylaxis in intraoral bone grafting procedures: A pilot study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol. 2003, 96, 669–672. [Google Scholar] [CrossRef]
- Mauceri, R.; Campisi, G.; Matranga, D.; Mauceri, N.; Pizzo, G.; Melilli, D. The Role of Antibiotic Prophylaxis in Reducing Bacterial Contamination of Autologous Bone Graft Collected from Implant Site. BioMed Res. Int. 2017, 2017, 2175019. [Google Scholar] [CrossRef]
- Chiesa-Estomba, C.M.; Ninchritz, E.; González-García, J.A.; Larruscain-Sarasola, E.; Sistiaga-Suarez, J.A.; Altuna-Mariezcurrena, X. Antibiotic Prophylaxis in Clean Head and Neck Surgery: An Observational Retrospective Single-Centre Study. Ear. Nose. Throat J. 2019, 98, 362–365. [Google Scholar] [CrossRef]
- Danda, A.K.; Ravi, P. Effectiveness of postoperative antibiotics in orthognathic surgery: A meta-analysis. J. Oral Maxillofac. Surg. 2011, 69, 2650–2656. [Google Scholar] [CrossRef] [PubMed]
- Tomás, I.; Alvarez, M.; Limeres, J.; Tomás, M.; Medina, J.; Otero, J.L.; Diz, P. Effect of a chlorhexidine mouthwash on the risk of postextraction bacteremia. Infect. Control Hosp. Epidemiol. 2007, 28, 577–582. [Google Scholar] [CrossRef] [PubMed]
- Stosowanie Antybiotyków w Profilaktyce Okołooperacyjnej. Available online: http://antybiotyki.edu.pl/wp-content/uploads/Rekomendacje/stosowanie-antybiotykow.pdf (accessed on 22 September 2022).
- Iocca, O.; Copelli, C.; Ramieri, G.; Zocchi, J.; Savo, M.; Di Maio, P. Antibiotic prophylaxis in head and neck cancer surgery: Systematic review and Bayesian network meta-analysis. Head Neck 2022, 44, 254–261. [Google Scholar] [CrossRef] [PubMed]
- European Committee on Antimicrobial Susceptibility Testing. Breakpoints Tables for Interpretation of MICs and Zones Diameters, Version 9.0. 2019. Available online: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_9.0_Breakpoint_Tables.pdf (accessed on 22 September 2022).
- Cruse, P.J.E.; Foord, R. The Epidemiology of Wound Infection: A 10-Year Prospective Study of 62,939 Wounds. Surg. Clin. N. Am. 1980, 60, 27–40. [Google Scholar] [CrossRef]
- Cheng, H.Q. Antibiotic Prophylaxis of Surgical Site Infections. In Current Medical Diagnosis & Treatment 2021; Papadakis, M.A., McPhee, S.J., Rabow, M.W., Eds.; McGraw-Hill Education: New York, NY, USA, 2021. [Google Scholar]
- Perdikaris, G.; Pefanis, A.; Giamarellou, E. Prophylactic and Therapeutic Use of Antibiotics in Dentistry. In Oral Surgery; Fragiskos, F.D., Ed.; Springer: Berlin/Heidelberg, Germany, 2007; pp. 349–364. ISBN 978-3-540-49975-6. [Google Scholar]
- Steinberg, J.P.; Braun, B.I.; Hellinger, W.C.; Kusek, L.; Bozikis, M.R.; Bush, A.J.; Dellinger, E.P.; Burke, J.P.; Simmons, B.; Kritchevsky, S.B.; et al. Timing of antimicrobial prophylaxis and the risk of surgical site infections: Results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann. Surg. 2009, 250, 10–16. [Google Scholar] [CrossRef] [PubMed]
- Scottish Intercollegiate Guidelines Network. Antibiotic Prophylaxis in Surgery. A National Clinical Guideline. Available online: http://medicinainterna.net.pe/images/guias/GUIA_PARA_LA_PROFILAXIS_ANTIBIOTICA_EN_CIRUGIA.pdf (accessed on 22 September 2022).
- Hauser, C.J.; Adams, C.A.; Eachempati, S.R. Council of the Surgical Infection Society Surgical Infection Society guideline: Prophylactic antibiotic use in open fractures: An evidence-based guideline. Surg. Infect. 2006, 7, 379–405. [Google Scholar] [CrossRef] [PubMed]
Authors | Material and Methods | Conclusions |
---|---|---|
Abu-Ta’a, “Adjunctive Systemic Antimicrobial Therapy vs. Asepsis in Conjunction with Guided Tissue Regeneration” [14] | 40 patients: 20 with PAP; 20 without PAP DFDBA procedure: bone allograft Clinical observation for lack of complications | No benefits of PAP |
Funahara et al., “Prevention of Surgical Site Infection after Oral Cancer Surgery by Topical Tetracycline” [15] | Research group n = 61 (administration of tetracycline ointment to the back of the tongue every 6 h for 48 h after surgery for oral cancer); control group n = 56 Multifactorial analysis and symptoms, and swabs | Regional use of tetracycline as an effective way to prevent wound infection after oral cancer surgery |
Arteagoitia et al., “Amoxicillin/Clavulanic Acid 2000/125 Mg to Prevent Complications Due to Infection Following Completely Bone-Impacted Lower Third Molar Removal” [5] | Research group n = 58, single administration of APO before extraction of third molar tooth; placebo n = 60, Clinical observation for lack of complications | No benefits of PAP |
Bortoluzzi et al., “A Single Dose of Amoxicillin and Dexamethasone for Prevention of Postoperative Complications in Third Molar Surgery” [16] | Group of 50 patients with extracted third molar teeth Group 1 (G1), prophylactic dose of 2 g amoxicillin and 8 mg dexamethasone Group 2 (G2), prophylactic dose of 2 g amoxicillin and 8 mg placebo Group 3 (G3), prophylactic dose of 8 mg dexamethasone and 2 g placebo Group 4 (G4), placebo Clinical observation for lack of complications | No benefits of PAP |
Lindeboom and van den Akker, “A Prospective Placebo-Controlled Double-Blind Trial of Antibiotic Prophylaxis in Intraoral Bone Grafting Procedures” [17] | Group of 20 patients Prevention n = 10 Placebo n = 10 Intraoral bone grafts Clinical observation up to 3 months | Efficiency of PAP confirmed |
Mauceri et al., “The Role of Antibiotic Prophylaxis in Reducing Bacterial Contamination of Autologous Bone Graft Collected from Implant Site” [18] | 34 patients: 18 with PAP (1 gr. amoxicillin + clavulanic acid; 12 h and 1 h before surgery) 16 without PAP 15 days before the procedure, oral hygiene session and instruction, and 0.2% chlorhexidine mouthrinse twice a day; A surgical swab was taken and then the strains found were evaluated | The tested antibiotic prophylaxis regimen reduces but does not eliminate the risk of infection |
Chiesa-Estomba et al., “Antibiotic Prophylaxis in Clean Head and Neck Surgery” [19] | Retrospective SSI assessment Without prevention, n = 77 Antibiotic prophylaxis, n = 109 Resection of the submandibular gland, parotid gland resection, cystic mandibular resection | A prophylactic antibiotic is not necessary for clean, gentle head and neck surgery |
Danda and Ravi, “Effectiveness of Postoperative Antibiotics in Orthognathic Surgery” [20] | Meta-analysis of five clinical trials involving 532 patients undergoing orthognathic surgery. Wound infection occurred in 30 of 268 patients in the short-term prophylaxis group (frequency, 11.2%) and in 10 of 264 patients in the prolonged treatment group (frequency 3.8%) | According to the authors, extended antibiotic therapy was more effective in reducing the risk of postoperative wound infection, but they stressed that more research is needed to harmonize the appropriate regimen |
Mauceri et al., “The Role of Antibiotic Prophylaxis in Reducing Bacterial Contamination of Autologous Bone Graft Collected from Implant Site” [18] | Patients with PAP in autologous transplants around the implant Research group—15 days before the procedure, given instructions for rinsing the mouth with chlorhexidine and PAP Control group without PAP Cultures were demonstrated for specific strains in both groups | PAP reduces but does not eliminate the infection |
Parameter | Trauma Patients | Non-Trauma Patients | |
---|---|---|---|
Procedure duration | up to 60 min | 19 | 23 |
above 60 min | 24 | 17 | |
Sex | female | 4 | 21 |
male | 29 | 19 | |
Access to surgical field | extraoral | 14 | 2 |
intraoral | 20 | 31 | |
intra- and extraoral | 9 | 7 |
Group of Microorganisms | Trauma Patients n = 43 | Non-Trauma Patients n = 40 | ||
---|---|---|---|---|
Beginning of Procedure | End of Procedure | Beginning of Procedure | End of Procedure | |
Gram (+) cocci | 54 | 42 | 39 | 37 |
Gram (−) cocci | 1 | 1 | 5 | 2 |
Gram (+) rods | 0 | 0 | 1 | 0 |
Gram (−) rods | 5 | 2 | 7 | 7 |
Fungi | 8 | 3 | 0 | 1 |
IN TOTAL: | 68 | 48 | 52 | 47 |
Species of Microorganisms | Trauma Patients n = 43 | Non-Trauma Patients n = 40 | ||
---|---|---|---|---|
Beginning of Procedure | End of Procedure | Beginning of Procedure | End of Procedure | |
Gram (+) cocci: | ||||
Enterococcus faecalis | 1 | 0 | 0 | 0 |
Enterococcus saccharolyticus | 1 | 0 | 0 | 0 |
Lactococcus garvieae | 1 | 0 | 0 | 0 |
Staphylococcus aureus MSSA | 0 | 0 | 0 | 1 |
Staphylococcus capitis | 3 | 2 | 0 | 0 |
Staphylococcus hominis | 1 | 0 | 0 | 1 |
Staphylococcus epidermidis MSCNS | 14 | 17 | 12 | 7 |
Staphylococcus lentus | 1 | 1 | 0 | 0 |
Staphylococcus saprophyticus | 0 | 0 | 1 | 0 |
Streptococcus agalactiae | 0 | 1 | 0 | 1 |
Streptococcus anginosus | 3 | 2 | 0 | 4 |
Streptococcus constellatus | 0 | 1 | 0 | 3 |
Streptococcus gordoni | 0 | 0 | 0 | 1 |
Streptococcus mitis | 7 | 4 | 9 | 3 |
Streptococcus mutans | 1 | 1 | 1 | 0 |
Streptococcus sanguinis | 2 | 2 | 4 | 3 |
Streptococcus parasanguinis | 7 | 7 | 3 | 6 |
Streptococcus pneumonia | 0 | 0 | 0 | 1 |
Streptococcus pseudoporcinus | 0 | 0 | 1 | 0 |
Streptococcus salivarius | 2 | 2 | 2 | 3 |
Streptococcus thoraltensis | 0 | 0 | 1 | 0 |
Streptococcus viridans | 5 | 1 | 5 | 3 |
Streptococcus vestibularis | 0 | 1 | 0 | 0 |
Gram (−)cocci: | ||||
Moraxella catarrhalis | 0 | 0 | 1 | 1 |
Neisseria spp. | 1 | 1 | 4 | 1 |
Gram (+) rods: | ||||
Rothia dentocariosa | 0 | 0 | 1 | 0 |
Gram (−) rods: | ||||
Acinetobacter baumanii | 1 | 0 | 0 | 1 |
Enterobacter cloacae | 0 | 0 | 2 | 1 |
Escherichia coli | 1 | 1 | 2 | 2 |
Haemophilus influenza | 1 | 1 | 2 | 2 |
Haemophilus parainfluenzae | 0 | 0 | 1 | 0 |
Klebsiella pneumonia | 1 | 0 | 0 | 0 |
Pseudomonas aeruginosa | 1 | 0 | 0 | 1 |
Fungi: | ||||
Candida albicans | 8 | 3 | 0 | 0 |
Candida crusei | 0 | 0 | 0 | 1 |
Negative cultures: | 5 | 9 | 5 | 8 |
Groups of Microorganisms | Trauma Patients n = 43 | Non-Trauma Patients n = 40 | ||
---|---|---|---|---|
Beginning of Procedure | End of Procedure | Beginning of Procedure | End of Procedure | |
Gram (+) cocci | 14 | 13 | 10 | 13 |
Gram (−) cocci | 1 | 1 | 2 | 2 |
Gram (+) rods | 0 | 0 | 1 | 0 |
Gram (−) rods | 5 | 2 | 4 | 5 |
Fungi | 1 | 1 | 0 | 1 |
IN TOTAL: | 21 | 17 | 17 | 21 |
Groups of Microorganisms | Trauma Patients n = 43 | Non-Trauma Patients n = 40 | ||
---|---|---|---|---|
Procedure Lasting Up to 60 min n = 19 | Procedure Lasting over 60 min n = 24 | Procedure Lasting Up to 60 min n = 23 | Procedure Lasting over 60 min n = 17 | |
Gram (+) cocci | 18 | 24 | 20 | 17 |
Gram (−) cocci | 1 | 0 | 1 | 1 |
Gram (−) rods | 1 | 1 | 3 | 4 |
Fungi | 2 | 1 | 0 | 1 |
IN TOTAL: | 22 | 26 | 24 | 23 |
Type of Microorganisms | Trauma Patients n = 43 | Non-Trauma Patients n = 40 | ||
---|---|---|---|---|
Procedure Lasting Up to 60 min n = 19 | Procedure Lasting over 60 min n = 24 | Procedure Lasting Up to 60 min n = 23 | Procedure Lasting over 60 min n = 17 | |
Gram (+) cocci: | ||||
Staphylococcus aureus MSSA | 0 | 0 | 0 | 1 |
Staphylococcus capitis | 1 | 1 | 0 | 0 |
Staphylococcus hominis | 0 | 0 | 0 | 1 |
Staphylococcus epidermidis MSCNS | 6 | 11 | 4 | 3 |
Staphylococcus lentus | 0 | 1 | 0 | 0 |
Streptococcus agalactiae | 1 | 0 | 1 | 0 |
Streptococcus anginosus | 0 | 2 | 2 | 2 |
Streptococcus constellatus | 1 | 0 | 2 | 1 |
Streptococcus gordoni | 0 | 0 | 1 | 0 |
Streptococcus mitis | 2 | 2 | 1 | 2 |
Streptococcus mutans | 1 | 0 | 0 | 0 |
Streptococcus sanguinis | 1 | 1 | 2 | 1 |
Streptococcus parasanguinis | 3 | 4 | 4 | 2 |
Streptococcus pneumonia | 0 | 0 | 1 | 0 |
Streptococcus salivarius | 0 | 2 | 2 | 1 |
Streptococcus viridans | 1 | 0 | 0 | 3 |
Streptococcus vestibularis | 1 | 0 | 0 | 0 |
Gram (−) cocci: | ||||
Moraxella catarrhalis | 0 | 0 | 0 | 1 |
Neisseria spp. | 1 | 0 | 1 | 0 |
Gram (−) rods: | ||||
Acinetobacter baumanii | 0 | 0 | 1 | 0 |
Enterobacter cloacae | 0 | 0 | 0 | 1 |
Escherichia coli | 1 | 0 | 0 | 2 |
Haemophilus influenza | 0 | 1 | 2 | 0 |
Pseudomonas aeruginosa | 0 | 0 | 0 | 1 |
Fungi: | ||||
Candida albicans | 2 | 1 | 0 | 0 |
Candida crusei | 0 | 0 | 0 | 1 |
Negative cultures: | 5 | 4 | 6 | 2 |
Groups of Microorganisms | Trauma Patients n = 43 | Non-Trauma Patients n = 40 | ||
---|---|---|---|---|
Procedure Lasting Up to 60 min n = 19 | Procedure Lasting over 60 min n = 24 | Procedure Lasting Up to 60 min n = 23 | Procedure Lasting over 60 min n = 17 | |
Gram (+) cocci | 10 | 8 | 10 | 10 |
Gram (−) cocci | 1 | 0 | 1 | 1 |
Gram (−) rods | 1 | 1 | 2 | 3 |
Fungi | 1 | 1 | 0 | 1 |
IN TOTAL: | 13 | 10 | 13 | 15 |
Groups of Microorganisms | Trauma Patients n = 43 | Non-Trauma Patients n = 40 | ||||
---|---|---|---|---|---|---|
Procedure with Intraoral Access n = 20 | Procedure with Extraoral Access n = 14 | Procedure with Intra- and Extraoral Access n = 9 | Procedure with Intraoral Access n = 31 | Procedure with Extraoral Access n = 2 | Procedure with Intra- and Extraoral Access n = 7 | |
Gram (+) cocci | 21 | 9 | 11 | 33 | 0 | 4 |
Gram (−) cocci | 1 | 0 | 0 | 2 | 0 | 0 |
Gram (−) rods | 2 | 0 | 0 | 3 | 0 | 3 |
Fungi | 3 | 0 | 0 | 1 | 0 | 0 |
IT TOTAL: | 27 | 9 | 11 | 39 | 0 | 7 |
Types of Microorganisms | Trauma Patients n = 43 | ||
---|---|---|---|
Procedure with Intraoral Access n = 20 | Procedure with Extraoral Access n = 14 | Procedure with Intra- and Extraoral Access n = 9 | |
Gram (+) cocci: | |||
Staphylococcus capitis | 0 | 1 | 1 |
Staphylococcus epidermidis MSCNS | 4 | 5 | 8 |
Staphylococcus lentus | 0 | 0 | 1 |
Streptococcus agalactiae | 0 | 1 | 0 |
Streptococcus anginosus | 2 | 0 | 0 |
Streptococcus constellatus | 1 | 0 | 0 |
Streptococcus mitis | 4 | 0 | 0 |
Streptococcus mutans | 1 | 0 | 0 |
Streptococcus sanguinis | 2 | 0 | 0 |
Streptococcus parasanguinis | 5 | 1 | 1 |
Streptococcus salivarius | 2 | 0 | 0 |
Streptococcus viridans | 1 | 0 | 0 |
Streptococcus vestibularis | 0 | 1 | 0 |
Gram (−) cocci: | |||
Neisseria spp. | 1 | 0 | 0 |
Gram (−) rods: | |||
Escherichia coli | 1 | 0 | 0 |
Haemophilus influenzae | 1 | 0 | 0 |
Fungi: | |||
Candida albicans | 3 | 0 | 0 |
Negative cultures: | 3 | 6 | 0 |
Types of Microorganisms | Non-Trauma Patients n = 40 | ||
---|---|---|---|
Procedure with Intraoral Access n = 31 | Procedure with Extraoral Access n = 2 | Procedure with Intra- and Extraoral Access n = 7 | |
Gram (+) cocci: | |||
Staphylococcus aureus MSSA | 1 | 0 | 0 |
Staphylococcus hominis | 1 | 0 | 0 |
Staphylococcus epidermidis MSCNS | 5 | 0 | 2 |
Streptococcus agalactiae | 1 | 0 | 0 |
Streptococcus anginosus | 4 | 0 | 0 |
Streptococcus constellatus | 3 | 0 | 0 |
Streptococcus gordoni | 1 | 0 | 0 |
Streptococcus mitis | 2 | 0 | 1 |
Streptococcus sanguinis | 3 | 0 | 0 |
Streptococcus parasanguinis | 6 | 0 | 0 |
Streptococcus pneumoniae | 1 | 0 | 0 |
Streptococcus salivarius | 3 | 0 | 0 |
Streptococcus viridans | 2 | 0 | 1 |
Gram (−) cocci: | |||
Moraxella catarrhalis | 1 | 0 | 0 |
Neisseria spp. | 1 | 0 | 0 |
Gram (−) rods: | |||
Acinetobacter baumanii | 1 | 0 | 0 |
Enterobacter cloacae | 0 | 0 | 1 |
Escherichia coli | 1 | 0 | 1 |
Haemophilus influenzae | 1 | 0 | 0 |
Pseudomonas aeruginosa | 0 | 0 | 1 |
Fungi: | |||
Candida crusei | 1 | 0 | 0 |
Negative cultures: | 5 | 2 | 1 |
Types of Microorganisms | Trauma Patients n = 43 | Non-Trauma Patients n = 40 | ||||
---|---|---|---|---|---|---|
Procedure with Intraoral Access n = 20 | Procedure with Extraoral Access n = 14 | Procedure with Intra- and Extraoral Access n = 9 | Procedure with Intraoral Access n = 31 | Procedure with Extraoral Access n = 2 | Procedure with Intra- and Extraoral Access n = 7 | |
Gram (+) cocci | 9 | 5 | 4 | 13 | 0 | 3 |
Gram (−) cocci | 1 | 0 | 0 | 2 | 0 | 0 |
Gram (−) rods | 2 | 0 | 0 | 3 | 0 | 3 |
Fungi | 1 | 0 | 0 | 1 | 0 | 0 |
IN TOTAL: | 13 | 5 | 4 | 19 | 0 | 6 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Niedzielska, I.; Kotowski, M.; Mertas, A.; Bąk, M.; Barnaś, S.; Niedzielski, D. Analysis of the Validity of Perioperative Antibiotic Prophylaxis in Maxillofacial Surgery. J. Clin. Med. 2022, 11, 5812. https://doi.org/10.3390/jcm11195812
Niedzielska I, Kotowski M, Mertas A, Bąk M, Barnaś S, Niedzielski D. Analysis of the Validity of Perioperative Antibiotic Prophylaxis in Maxillofacial Surgery. Journal of Clinical Medicine. 2022; 11(19):5812. https://doi.org/10.3390/jcm11195812
Chicago/Turabian StyleNiedzielska, Iwona, Marcin Kotowski, Anna Mertas, Michał Bąk, Szczepan Barnaś, and Damian Niedzielski. 2022. "Analysis of the Validity of Perioperative Antibiotic Prophylaxis in Maxillofacial Surgery" Journal of Clinical Medicine 11, no. 19: 5812. https://doi.org/10.3390/jcm11195812
APA StyleNiedzielska, I., Kotowski, M., Mertas, A., Bąk, M., Barnaś, S., & Niedzielski, D. (2022). Analysis of the Validity of Perioperative Antibiotic Prophylaxis in Maxillofacial Surgery. Journal of Clinical Medicine, 11(19), 5812. https://doi.org/10.3390/jcm11195812